Article Details
Retrieved on: 2023-11-10 16:10:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Obinutuzumab is currently approvedopens in a new tab or window only for treating hematologic malignancies, but its manufacturer, Roche's Genentech ...
Article found on: www.medpagetoday.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here